Dent Neurologic


Generation HD-2

This study will evaluate the safety, biomarkers, and efficacy of tominersen compared with a placebo in participants with prodromal and early manifest Huntington’s Disease.

Inclusion Criteria:

Visit link below for more info:

Ages Eligible for Study:  25 Years to 50 Years   (Adult)
Sexes Eligible for Study:  All

Dr Michelle Rainka

Heather MacNamara

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Scroll to Top